MicroRNA-130a Increases and Predicts Cardiotoxicity during Adjuvant Chemotherapy in Human Epidermal Growth Factor Receptor-2-Positive Breast Cancer

PURPOSE: This study aimed to investigate the changes in microRNA-130a (miR-130a) and its correlation with cardiotoxicity during epirubicin/cyclophosphamide followed by docetaxel plus trastuzumab (EC-D+T) adjuvant chemotherapy in human epidermal growth factor receptor-2-positive (HER2(+)) breast canc...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Qiang, Ren, Yanbin, Hou, Aijun, Guo, Jing, Mao, Zhezhe, Liu, Shaojun, Wang, Boya, Bai, Zhichao, Hou, Xiaoying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Breast Cancer Society 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090801/
https://www.ncbi.nlm.nih.gov/pubmed/33818020
http://dx.doi.org/10.4048/jbc.2021.24.e15

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090801/
https://www.ncbi.nlm.nih.gov/pubmed/33818020
http://dx.doi.org/10.4048/jbc.2021.24.e15

Ejemplares similares